Role of Proton Pump Inhibitors in Laryngopharyngeal Reflux: Clinical Evaluation in a North Indian Population

  • Anuja BhargavaEmail author
  • S. M. Faiz
  • Mrinal Ranjan Srivastava
  • Mohammad Shakeel
  • Nafas Jeet Singh
Original Article


There has been an escalation of patients presenting with symptoms of Laryngopharyngeal reflux disease (LPRD) in the otorhinolaryngology clinics due to life style and dietary changes. This study was undertaken to evaluate the effect of various proton pump inhibitors in the treatment of LPRD using Reflux symptom index (RSI) and Reflux finding score (RFS). This was a prospective study conducted from June 2016 to February 2017 with a total of 240 patients with symptoms and signs of LPR. The patients were divided into 5 groups. Each group was subjected to particular proton pump inhibitor. There were 124 males 116 females with a mean age 34.3 and rural to urban ratio being 11. After 3 months, RFS and RSI score within each group, improved significantly with Proton pump inhibitor therapy. In our study patients who were treated with omeprazole 20 mg twice daily had the highest improvement in laryngeal symptoms and laryngeal findings. We conclude emphasizing the effectiveness of proton pump inhibitors with incorporation of lifestyle modification in the successful management of LPRD.


Laryngopharyngeal reflux disease (LPRD) Proton pump inhibitors (ppi) Reflux symptom index (RSI Reflux finding score (RFS) 


Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Ethical Approval

All procedures performed involving human participants were in accordance wit h the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


  1. 1.
    Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294:1534–1540CrossRefGoogle Scholar
  2. 2.
    HB EI-Serag (2007) Time trends of gastroesophageal reflux disease; a systematic review. Clin Gastroenterol Hepatol 5:17–26CrossRefGoogle Scholar
  3. 3.
    Altman KW, Stephens RM (2005) Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope 115:1145–1153CrossRefGoogle Scholar
  4. 4.
    Koufman JA (2011) Low acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and implications. Ann Otol Rhinol Laryngol 120:281–287CrossRefGoogle Scholar
  5. 5.
    Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Nat cancer Inst 97:142–146CrossRefGoogle Scholar
  6. 6.
    Koufman JA (2012) Potential benefits of ph 8.8 alkaline drinking water as adjunct to treatment of reflux disease. Ann Otol Rhinol Laryngol 121:431–434CrossRefGoogle Scholar
  7. 7.
    Fraser AG (1994) Review article: gastroesophageal reflux and laryngeal symptoms. Aliment Pharmacol Ther 8:265–272CrossRefGoogle Scholar
  8. 8.
    Vaezi M, Hicks D, Abelson T, Richter J (2003) Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 1:333–344CrossRefGoogle Scholar
  9. 9.
    Koufman JA (1991) The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24 hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development laryngeal injury. Laryngoscope 101(suppl 52):1–78CrossRefGoogle Scholar
  10. 10.
    Belafsky PC, Postma GN, Koufman JA (2002) Validity and reliability of the reflux symptom index (RSI). J Voice 16(2):274–277CrossRefGoogle Scholar
  11. 11.
    Beaver ME, Stasney CR, Weitzel E et al (2003) Diagnosis of laryngopharyngeal reflux disease with digital imaging. Otolaryngol Head Neck Surg 128(1):103–108CrossRefGoogle Scholar
  12. 12.
    Belafsky PC, Postma GN, Koufman JA (2001) The validity and reliability of the reflux finding score (RFS). Laryngoscope 111(8):1313–1317CrossRefGoogle Scholar
  13. 13.
    Postma GN, Belafsky PC, Aviv JE, Koufman JA (2002) Laryngopharyngeal reflux testing. Ear Nose Throat J 81(9 Suppl 2):14–18Google Scholar
  14. 14.
    Belafsky PC, Postma GN, Koufman JA (2002) Validity and reliability of the reflux symptom index. J Voice 16:274–277. CrossRefGoogle Scholar
  15. 15.
    Belafsky PC, Postma GN (2001) The validity and reliability of reflux finding score. Laryngoscope 111:1313–1317CrossRefGoogle Scholar
  16. 16.
    Feng GJ, Zhang LH, Zhao LL, Liu YL (2008) A pilot study on diagnosing laryngopharyngeal reflux disease by pH monitoring in laryngopharynx. Zhonghua Yi Xue Za Zhi 88(12):805–808Google Scholar
  17. 17.
    Ahmed TF, Khandwala F, Abelson TI et al (2006) Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 101:470–478CrossRefGoogle Scholar
  18. 18.
    Leite LP, Johnston BT, Just RJ, Castell DO (1996) Persistant acid secretion during omeprazole therapy a, a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J gastroenterol 91:1527–1531Google Scholar
  19. 19.
    Amin MR, Postma GN, Johnson P, Digges N, Koufmann JA (2001) Proton pump inhibitors resistance in laryngopharyngeal reflux. Otolaryngol Head Neck Surg 125:374–378CrossRefGoogle Scholar
  20. 20.
    Park W, Hicks DM, Khandwala F et al (2005) Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115:1230–1238CrossRefGoogle Scholar
  21. 21.
    Bough JR et al (1995) Gastroesophageal reflux laryngitis resistant to omeprazole therapy. Voice 9:205–211CrossRefGoogle Scholar
  22. 22.
    Katz PO, Castell DO (2000) Medical therapy of gastroesophageal reflux disease. Am J Med 4a:170s–177sCrossRefGoogle Scholar
  23. 23.
    Horn J (2000) The proton pump inhibitors similarities and differences. Clin Ther 22:266–280CrossRefGoogle Scholar
  24. 24.
    Berardi RR (2000) A critical evaluation of proton pump inhibitors in the treatment of gastroesophageal reflux disease. Am J Manag Care 6:S491–S505Google Scholar
  25. 25.
    Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. JAMA 294:1534–1540CrossRefGoogle Scholar
  26. 26.
    Bove MJ, Rosen C (2006) Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg 14:116–123CrossRefGoogle Scholar
  27. 27.
    Jasperson D, Weber R (1996) Effect of omeprazole on the course of associated esophagitis and laryngitis. J Gastroenterol 31:765–776CrossRefGoogle Scholar
  28. 28.
    Kamel PL, Hanson D (1994) Omeprazole for the treatment of posterior laryngitis. Am J Med 96:321–326CrossRefGoogle Scholar
  29. 29.
    Wo JM, Hunter JG (1997) Dual-channel ambulatory pH monitoring-a useful diagnostic tool. Dig Dis Sci 42:2222–2226CrossRefGoogle Scholar
  30. 30.
    Hanson DG, Kamel PL et al (1995) Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 104:550–555CrossRefGoogle Scholar
  31. 31.
    Pieter Noordzij J, Khidir A (2002) Correlation of pH probe measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 112(12):2192–2195CrossRefGoogle Scholar
  32. 32.
    Tauber S, Gross M (2002) Association of laryngopharyngeal symptoms with gastroesophageal reflux disease. Laryngoscope 112(5):879–886CrossRefGoogle Scholar
  33. 33.
    Williams RB, Szczesniak MM (2004) Predictors of outcome in an open label, therapeutic trial of high dose omeprazole in laryngitis. Am J Gastroenterol 99:777–785CrossRefGoogle Scholar
  34. 34.
    Delgaudio JM, Waring P (2003) Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 113:598–601CrossRefGoogle Scholar
  35. 35.
    Issing WJ, Karkos PD (2004) Dual probe 24 hour ambulatory pH monitoring for diagnosis of laryngopharyngeal reflux. J Laryngol Otol 118:845–848CrossRefGoogle Scholar
  36. 36.
    Bilgen C, Ogut F (2003) The comparison of empiric proton pump inhibitor trial versus 24 hour double probe Ph monitoring in laryngopharyngeal reflux. J Laryngol Otol 117:386–390CrossRefGoogle Scholar
  37. 37.
    Toros SZ, Toros AB (2008) Association of laryngopharyngeal manifestation and gastroesophageal reflux. Eur Arch Otorhinolaryngol 266(3):403–409CrossRefGoogle Scholar
  38. 38.
    Zelenik K, Matousek P, Tedla M, Syrovatka J, Kominek P (2013) Extraesophageal reflux : what is the best parameter for pH-monitoring data analysis from the perspective of patient response to proton pump inhibitors?. Gastroenterol Res Pract 2013:5. Article ID 736486Google Scholar
  39. 39.
    Mesallam TA, Stemple JC, Sobeih TM, Elluru RG (2007) Reflux symptom index versus reflux finding score. Ann Otol Rhinolaryngol 116(6):436–440CrossRefGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 2018

Authors and Affiliations

  1. 1.Department of ENTEra’s Lucknow Medical College and HospitalLucknowIndia
  2. 2.Department of Community MedicineEra’s Lucknow Medical College and HospitalLucknowIndia

Personalised recommendations